NewGenIvf Group Limited (NIVF) Revenue History
Annual and quarterly revenue from 2021 to present
NIVF Revenue Over Time (2021–2025)
NIVF Revenue Growth History
2 of 4 years with positive growth- FY2021 revenue growth
- N/A
- FY2022 revenue growth
- +44.3%
- FY2023 revenue growth
- -13.6%
- FY2024 revenue growth
- +5.8%
- FY2025 revenue growth
- -13.0%
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $1.3M | -16.2% |
| Q4 2023 | $1.5M | — |
| Q3 2023 | $0 | — |
| Q4 2022 | $0 | — |
Revenue Breakdown
NIVF's revenue distribution by segment and geography
By Geography
NIVF Revenue Analysis (2021–2025)
Current Revenue & Growth
As of June 26, 2026, NewGenIvf Group Limited (NIVF) generated trailing twelve-month (TTM) revenue of $2.8 million, reflecting significant decline in growth of -16.2% year-over-year. The most recent quarter (Q4 2024) recorded $1.3 million in revenue, down 16.2% sequentially.
Historical Growth Trajectory
NIVF's historical revenue data shows a 3-year CAGR of -7.4%. NewGenIvf Group Limited's highest annual revenue of $5.9 million was recorded in 2022.
Peer Comparison
Compared to Healthcare sector peers — including NTRA (+36.6% YoY), PGNY (+6.6% YoY), and TMHC (-9.0% YoY) — NIVF has underperformed the peer group in revenue growth. Compare NIVF vs NTRA →
NIVF Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NIVFCurrent | $3M | -16.2% | - | -226.9% | |
 NTRA | $2.3B | +36.6% | +42.6% | -13.4% | |
 PGNY | $1.3B | +6.6% | +30.2% | 6.6% | |
 TMHC | $8.1B | -9.0% | +5.8% | 14.0% | |
 HIMS | $2.3B | +32.8% | +73.6% | 4.5% | |
 ILMN | $4.3B | +1.2% | +6.0% | 19.9% |
NIVF Historical Revenue Data (2021–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $4.7M | -13.0% | $956K | 20.2% | $-10,726,461 | -226.9% |
| 2024 | $5.4M | +5.8% | $1.8M | 33.6% | $-1,160,000 | -21.4% |
| 2023 | $5.1M | -13.6% | $1.7M | 32.7% | $42K | 0.8% |
| 2022 | $5.9M | +44.3% | $1.5M | 25.9% | $-504,907 | -8.5% |
| 2021 | $4.1M | - | $1.0M | 24.9% | $199K | 4.8% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
5+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
NIVF — Frequently Asked Questions
Quick answers to the most common questions about buying NIVF stock.
Is NIVF's revenue growth accelerating or slowing?
NIVF revenue is declining -16.2% year-over-year. TTM revenue fell to $3M, contrasting with the 5-year CAGR of N/A. The reversal reflects either macro headwinds or company-specific challenges.
What is NIVF's revenue history from 2021 to 2026?
NewGenIvf Group Limited (NIVF) revenue history spans 2021 to 2026. TTM revenue as of 2026 is $3M, growing at -16.2% YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is NIVF's long-term revenue growth rate (CAGR)?
NewGenIvf Group Limited's 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of -16.2% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for NIVF.
Why does NIVF's quarterly revenue fluctuate?
NIVF quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. NewGenIvf Group Limited's revenue data from 2021 to 2026 shows full historical quarterly detail on this page.
How is NIVF's revenue distributed by segment?
NIVF reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does NIVF's revenue compare to industry peers?
NewGenIvf Group Limited (NIVF) with TTM revenue of $3M and -16.2% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.